The importance of genomics data processing for drug discoveries. - Sigma IT
Skip to content
Life sciences

THe Importance of Genomics Data processing for drug Discoveries.

The emerging Role of Tech Companies and Software Solutions.

In the dynamic landscape of pharmaceutical research and development (R&D), genomics data processing is a game-changer for drug discovery and development. Recent advancements in this field, coupled with the influence of technology and tech companies, are revolutionizing drug discovery, accelerating industry innovations, and transforming data into life-saving drug discoveries. In this article, we explore the critical importance of genomics data processing in pharmaceutical R&D and the growing role of software solutions in shaping the future of genomics research. 

Why Genomics is Crucial for Pharmaceutical R&D? 

The rising cost of drug development, which has now exceeded $1-2 billion per approved drug, has compelled pharmaceutical R&D to invest heavily in genomics data processing. According to the research by Joseph A. DiMasi, Henry G. Grabowski, and Ronald W. Hansen (Innovation in the pharmaceutical industry: new estimates of R&D costs (1), the drug development process has become more expensive over the years. The total cost per approved new drug has risen significantly because the requirements are much bigger than in the past.  

Furthermore, the drug development journey is fraught with challenges. Only around 10% of drug candidates successfully progress from Phase 1 clinical trials to market approval (2). The majority of drug candidates fail during clinical trials, often due to issues related to efficacy and safety concerns. Therefore, advancing a drug candidate to Phase I clinical trials after rigorous optimization at the preclinical stage is considered a significant achievement for any pharmaceutical company or academic institution. 

The increasing cost and evolving requirements are among the primary reasons pharmaceutical R&D invests in genomics data processing. Genomics offers invaluable insights into the genetic basis of diseases and potential drug targets. Research has shown that drug targets supported by human genetic evidence of disease association are twice as likely to lead to approved drugs.

The emerging Role of Software Solutions in Genomics Research

As genomics data becomes more complex and vast, software solutions have become essential tools to handle and process genomics data efficiently. With cutting-edge technologies such as AI, machine learning, and big data analytics, researchers can extract meaningful insights from massive genomic datasets, paving the way for groundbreaking discoveries.  

Here are some key ways software solutions support researchers and clinicians in genomics research and development: 

  • Discovery of Novel Disease Insights: genomics data processing solutions can help uncover previously hidden associations between specific genetic variations and diseases. By identifying these relationships, researchers can better understand disease etiology, progression, and potential risk factors. This knowledge forms the foundation for developing targeted therapies and precision  
  • Identification of New Drug Targets: The insights derived from genomics data can shed light on potential drug targets that were previously unknown or overlooked. It opens up new avenues for drug discovery, as researchers can focus on developing therapies that specifically target the genetic components responsible for the disease. See example solution: Case study – solution for exploration of genomics signals)
  • Support for Patient Selection in Clinical Trials: solutions allow researchers to categorize patients based on their genetic profiles, helping to identify suitable candidates for clinical trials. By selecting patients with specific genetic characteristics that match the drug’s target, researchers can improve clinical trial efficiency and success rate, leading to faster drug approvals and better treatment outcomes. 
  • Accelerated Research and Development: software solutions streamline the analysis of vast and complex genomics datasets, making it more efficient and less time-consuming. This acceleration in data processing allows researchers to quickly generate hypotheses, test them, and make data-driven decisions, ultimately expediting the pace of research and drug development. See example solution: Case study – Genomics data analysis solution.

The Role of Technology Companies in Advancing Genomics Research 

In the fast-paced world of genomics research, technology companies have emerged as vital partners for life science organizations. Providing technological competencies, building innovative digital tools, and optimizing genomics data processing, these companies have an impact on accelerating drug discovery and ultimately transforming human lives for the better:  

  • Providing tech competencies
    Tech companies bring a wealth of expertise in software development and data analytics to the table. Collaborating with life science organizations, they offer specialized technological competencies essential for handling and making sense of vast and complex genomics datasets. 
  • Building Innovative Digital Technologies for Drug Discovery and Development: 
    Technology companies work hand in hand with life science researchers to create innovative software solutions tailored to the specific needs of genomic analysis. These digital tools accelerate data processing and streamline the identification of potential drug targets, allowing researchers to identify promising candidates with greater accuracy and efficiency. 
  • Optimizing Genomics Data Processing 
    Technology companies help build sophisticated algorithms and data processing pipelines that significantly speed up the exploration of genomics data. Through automation and advanced analytics, researchers can sift through massive datasets in record time, identifying relevant patterns and correlations that may otherwise be overlooked. 
  • Deriving Meaningful Insights from Complex Datasets 
     Technology companies assist researchers in making sense of data complexity by providing data visualization and analysis tools. These tools enable researchers to uncover meaningful insights, transforming raw data into actionable knowledge to inform critical drug development and patient care decisions. 


Genomics data processing has emerged as a game-changer in pharmaceutical R&D, offering unprecedented opportunities to discover and develop effective drugs. The increasing role of software solutions is accelerating the pace of genomics research and transforming the way drug discovery is approached. Tech companies are indispensable partners in advancing genomics research. Their contributions in providing technological competencies, building innovative digital tools, and optimizing genomics data processing have paved the way for accelerated drug discovery, precise, personalized medicine, and improved patient outcomes. The synergy between technology and genomics research unclocks endless possibilities, leading to groundbreaking discoveries.  


  1. Joseph DiMasi, Henry H Grabowski, Ronald W Hansen: “Innovation in the pharmaceutical industry: New estimates of R&D costs”
  2. Duxin Sun, Wei Gao, Hongxiang Hu, Simon Zhou, “Why 90% of clinical drug development fails and how to improve it? 

Never miss a thing With Sigma IT´s newsletter you get all the latest updates on everything we do.

With Sigma IT´s newsletter you get all the latest updates on everything we do.